Anti-Vinculin 抗体 [EPR8185]
Anti-Vinculin antibody [EPR8185] - Loading Control
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- 了解详情
5
(21 Reviews)
|
(524 Publications)
Anti-Vinculin antibody [EPR8185] (ab129002) is a rabbit monoclonal antibody detecting Vinculin in Western Blot, Flow Cytometry (Intra), IP, ICC/IF. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 350 publications
查看别名
Vinculin, Metavinculin, MV, VCL
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Immunofluorescent staining of HEK293 cells (fixed in 4% PFA, permeabilized with 0.1% Triton X 100) using purified ab129002 at a dilution of 1/50. An Alexa Fluor® 488 goat anti-rabbit antibody (ab150077) was used as the secondary at a dilution of 1/1000 and the cells were counter stained with DAPI. The negative controls are shown in the bottom middle and right hand panels. For negative control 1, the primary was used and then goat anti-mouse IgG was used at a dilution of 1/500. For negative control 2, a mouse primary antibody (ab7291) and anti-rabbit secondary antibody (ab150077) were used.
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Western blot : Anti-VCL antibody [EPR8185] (ab129002) staining at 1/10000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab129002 was shown to bind specifically to VCL. A band was observed at 124 kDa in wild-type A431 cell lysates with no signal observed at this size in VCL knockout cell line. To generate this image, wild-type and VCL knockout A431 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (ab129002) at 1/10000 dilution
Lane 1:
Wild-type A431 cell lysate
Lane 2:
Western blot - Human VCL (Vinculin) knockout A-431 cell line (<a href='/products/cell-lines/human-vcl-vinculin-knockout-a-431-cell-line-ab261898'>ab261898</a>) at 20 µg
Lane 2:
VCL knockout A431 cell lysate
Lane 3:
HeLa cell lysate
Lane 4:
Jurkat cell lysate
false
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Immunofluorescent staining of vinculin in HUVEC cells with unpurified ab129002 at 1/100 dilution.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Intracellular Flow Cytometry analysis of 293 (human embryonic kidney epithelial) cells labeling Vinculin (red) with ab129002 at a 1/200 dilution. Cells were fixed with 4% paraformaldehyde and permeabilized with 90% methanol. A goat anti-rabbit IgG (Alexa Fluorr® 488) (ab150077) was used as the secondary antibody at a 1/2000 dilution. Black - Rabbit monoclonal IgG (ab172730). Blue (unlabeled control) - Cells without incubation with the primary and secondary antibodies.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Flow cytometry overlay histogram showing wild-type A-431 (green line) and VCL knockout A-431 stained with ab129002 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab129002) (1x 106 in 100μl at 0.00032 μg/ml (1/6249999)) for 30min at 22°C.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C
Isotype control antibody Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control was used at the same concentration and conditions as the primary antibody (wild-type A-431 - black line, VCL knockout A-431 - grey line). Unlabelled sample was also used as a control (this line is not shown for the purpose of simplicity).
Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Flow cytometry overlay histogram showing left HeLa positive cells and right negative HeLa VCL KO stained with ab129002 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab129002) (1x 106 in 100μl at 0.008μg/ml (1/7875)) for 30min at 22°C.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C
Isotype control antibody (black line) was Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.
Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.
- IP
Lab
Immunoprecipitation - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
ab129002 (purified) at 1/20 immunoprecipitating vinculin in HeLa cells. Lane 1 : HeLa whole cell lysate (10 μg). Lane 2 : HeLa whole cell lysate (10 μg). Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab129002 in HeLa whole cell lysate. For western blotting, a HRP-conjugated goat anti-rabbit antibody was used as the secondary antibody (1/1000).
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Immunoprecipitation - Anti-Vinculin antibody [EPR8185] - Loading Control (ab129002)
Predicted band size: 124 kDa
false
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
The identity of the higher MW band at approximately 300 kDa is unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-BCL9 antibody [EPR29651-74] (<a href='/products/primary-antibodies/bcl9-antibody-epr29651-74-ab325937'>ab325937</a>) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) transfected with scrambled siRNA control fresh whole cell lysate at 20 µg
Lane 2:
293T transfected with siRNA specifically targeting BCL9 fresh whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 200 kDa,124 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Performed under reducing conditions.
In Western blot, ab325390 was shown to bind specifically to ATRX. Target of interest was observed at 310 kDa in wild-type A549 cell lysates (lane 1) with no signal observed at this size in ATRX knockout cell line (lane 2, knockout cell line ab287232).
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-ATRX antibody [EPR29209-280] (<a href='/products/primary-antibodies/atrx-antibody-epr29209-280-ab325390'>ab325390</a>) at 1/1000 dilution
Lane 1:
Wild-type A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
ATRX knockout A549 whole cell lysate
Lane 3:
Wild-type A549 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 310 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : CT26.WT, U-937.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 20944749, 17925379, 19692571, 25239622).
Samples are non-boiled as boiling may cause protein aggregation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (124 kDa) staining at 1/10000 dilution.
Exposure time : Lanes 1-2 : 59 seconds, lanes 3-4 : 26 seconds
All lanes:
Western blot - Anti-Pannexin 1 antibody [EPR28631-135] (<a href='/products/primary-antibodies/pannexin-1-antibody-epr28631-135-ab325529'>ab325529</a>) at 1/1000 dilution
Lane 1:
Neuro-2a (mouse neuroblastoma neuroblast) whole cell lysate at 20 µg
Lane 2:
CT26.WT (mouse colon fibroblast) whole cell lysate at 20 µg
Lane 3:
PANC-1 (human pancreatic epithelioid carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
U-937 (human histiocytic lymphoma monocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 37-50 kDa,124 kDa
false
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
293T cells express endogenously BCL9. This antibody does not cross-react with human BCL9L by WB.
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa); Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) (1 : 5000)(200KDa).
All lanes:
Western blot - Anti-BCL9 antibody [EPR29651-74] (<a href='/products/primary-antibodies/bcl9-antibody-epr29651-74-ab325937'>ab325937</a>) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) cells transfected with an empty vector containing a his-tag, fresh whole cell lysate at 20 µg
Lane 2:
293T cells transfected with a human BCL9 expression vector containing a his-tag, fresh whole cell lysate at 20 µg
Lane 3:
293T cells transfected with a human BCL9L expression vector containing a his-tag, fresh whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 200 kDa,124 kDa
false
Exposure time: 48s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Performed under reducing conditions.
In Western blot, ab325178 was shown to bind specifically to UBP43/USP18. Target of interest was observed at 35 kDa and 37kDa in wide-type A549 cell lysates (lane 2) with no signal observed at this size in USP18 knockout cell line (lane 3, 4) (lane 3, knockout cell line ab267178 / knockout cell lysate ab258752).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-UBP43/USP18 antibody [EPR26174-540] (<a href='/products/primary-antibodies/ubp43-usp18-antibody-epr26174-540-ab325178'>ab325178</a>) at 1/1000 dilution
Lane 1:
Untreated wide-type A549 (human lung carcinoma epithelial cell) whole cell lysate at 50 µg
Lane 2:
Wide-type A549 treated with 100U/ml IFN alpha (human) for 14 hours whole cell lysate at 50 µg
Lane 3:
Untreated USP18 knockout A549 whole cell lysate at 50 µg
Lane 4:
USP18 knockout A549 treated with 100U/ml IFN alpha (human) for 14 hours whole cell lysate at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 35 kDa,37 kDa,124 kDa
false
Exposure time: 3s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
The identity of the higher MW band at approximately 300 kDa is unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-BCL9 antibody [EPR29651-74] (<a href='/products/primary-antibodies/bcl9-antibody-epr29651-74-ab325937'>ab325937</a>) at 1/1000 dilution
All lanes:
SW620 (human colorectal adenocarcinoma epithelial cell) fresh whole cell lysate at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 200 kDa,124 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 22558357; PMID : 19166587).
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
The identity of the lower band at approximately 140 kDa is likely SET-NUP214 fusion protein.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
Exposure time : Lanes 1-2 : 180 seconds; Lanes 3 : 37 seconds
All lanes:
Western blot - Anti-NUP214 antibody [EPR29100-623] (<a href='/products/primary-antibodies/nup214-antibody-epr29100-623-ab325238'>ab325238</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 3:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 268 kDa,124 kDa
false
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : HEL, B16-F0, Beta-TC-6.
The identity of the bands lower than 130 kDa are unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-ITPR3 antibody [EPR25276-304] (<a href='/products/primary-antibodies/itpr3-antibody-epr25276-304-ab325503'>ab325503</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
A-172 (human brain glioblastoma cell ) whole cell lysate at 20 µg
Lane 3:
DLD-1 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
HEL (human erythroleukemia erythroblast) whole cell lysate at 20 µg
Lane 5:
bEnd.3 (mouse brain endothelial cell) whole cell lysate at 20 µg
Lane 6:
Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate at 20 µg
Lane 7:
B16-F0 (mouse melanoma epithelial-like cell) whole cell lysate at 20 µg
Lane 8:
Beta-TC-6 (mouse pancreas insulinoma beta cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/20000 dilution
Observed band size: 280 kDa,124 kDa
false
Exposure time: 81s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : HEL.
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-BCL9 antibody [EPR29651-74] (<a href='/products/primary-antibodies/bcl9-antibody-epr29651-74-ab325937'>ab325937</a>) at 1/1000 dilution
Lane 1:
IMR-32 (human neuroblastoma neuroblast) fresh whole cell lysate at 20 µg
Lane 2:
HEL (human erythroleukemia erythroblast) fresh whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 200 kDa,124 kDa
false
Exposure time: 37s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The identity of the bands below 300 kDa is unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
In Western blot, Anti-53BP1 antibody [EPR2172(2)] (ab175933) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-53BP1 (phospho S25) antibody [EPR27057-33] (<a href='/products/primary-antibodies/53bp1-phospho-s25-antibody-epr27057-33-ab315015'>ab315015</a>) at 1/1000 dilution
Lane 1:
Untreated wild-type HAP1 (human chronic myelogenous leukemia near-haploid cell line) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
Wild-type HAP1 treated with 100nM Calycin A for 30 minutes, whole cell lysate (untreated membrane) at 20 µg
Lane 3:
Untreated TP53BP1 knockout HAP1 whole cell lysate (untreated membrane) at 20 µg
Lane 4:
TP53BP1 knockout HAP1 treated with 100nM Calycin A for 30 minutes, whole cell lysate (untreated membrane) at 20 µg
Lane 5:
Untreated wild-type HAP1 whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 6:
Wild-type HAP1 treated with 100nM Calycin A for 30 minutes, whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 7:
Untreated TP53BP1 knockout HAP1 whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 8:
TP53BP1 knockout HAP1 treated with 100nM Calycin A for 30 minutes, whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 350 kDa,124 kDa
false
Exposure time: 3s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Lanes 1-2 are incubated with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/100000 and lanes 3-4 are incubated with Goat Anti-Rabbit IgG (HRP) at 1/2000.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
Exposure time : Lanes 1 and 3-4 : 180 seconds; Lane 2 : 26 seconds
All lanes:
Western blot - Anti-SMC1A antibody [EPR30532-7] (<a href='/products/primary-antibodies/smc1a-antibody-epr30532-7-ab325922'>ab325922</a>) at 1/1000 dilution
Lane 1:
Human spleen tissue lysate at 20 µg
Lane 2:
Human tonsil tissue lysate at 20 µg
Lane 3:
Mouse kidney tissue lysate at 20 µg
Lane 4:
Mouse liver tissue lysate at 20 µg
Secondary
Lanes 1 - 2:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Lanes 3 - 4:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 160 kDa,124 kDa
false
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, ab327707 was shown to bind specifically to WRN. Target of interest was observed at 200 kDa in wild-type HAP1 cell lysates (lane 1) with no signal observed at this size in WRN knockout cell lysates (lane 2).
Low expression : HT-29, PANC-1, SW1116.
The identity of the bands lower than 180 kDa are unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-Werner's syndrome helicase WRN antibody [EPR29645-145] (<a href='/products/primary-antibodies/werners-syndrome-helicase-wrn-antibody-epr29645-145-ab327707'>ab327707</a>) at 1/1000 dilution
Lane 1:
Wild-type HAP1 (human chronic myelogenous leukemia near-haploid cell) whole cell lysate at 20 µg
Lane 2:
WRN knockout HAP1 cell lysate at 20 µg
Lane 3:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Lane 4:
SK-N-MC (human brain epithelial cell) whole cell lysate at 20 µg
Lane 5:
HT-29 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 6:
PANC-1 (human pancreatic epithelioid carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 7:
SW1116 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 8:
Ramos (human burkitt's lymphoma b lymphocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 200 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST Low expression : HCT116, HEK-293 (PMID : 23743647). The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 11021599). In lane 1, the lysate was stored at -80°C prior to Western Blotting. The bands beneath the target band (320 kDa) are likey to be degradation products. In lanes 2-4, the lysates were freshly made and used for Western Blotting immediately to minimize protein degradation. In Western blot, anti- Vinculin antibody (ab129002) loading control staining at 1/10000 dilution.
All lanes:
Western blot - Anti-Collagen VII antibody [EPR27012-157] (<a href='/products/primary-antibodies/collagen-vii-antibody-epr27012-157-ab309143'>ab309143</a>) at 1/1000 dilution
Lane 1:
A431 (human epidermoid carcinoma epithelial cell) whole cell lysate at 40 µg
Lane 2:
A431 (human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
HCT116 (human colorectal carcinoma epithelial cell), whole cell lysate at 20 µg
Lane 4:
HEK-293 (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 320 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : brain.
The molecular weight is consistent with what have been described in literature (PMID : 12582180; 16754877).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
Exposure time : Lanes 1, 3 and 4 : 180 seconds; Lane 2 : 37 seconds
All lanes:
Western blot - Anti-MUC2 antibody [RM1281] (<a href='/products/primary-antibodies/muc2-antibody-rm1281-ab322964'>ab322964</a>) at 1/1000 dilution
Lane 1:
HT-29 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 50 µg
Lane 2:
Mouse colon tissue lysate at 20 µg
Lane 3:
Mouse small intestine tissue lysate at 20 µg
Lane 4:
Mouse brain tissue lysate at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 140-170 kDa,124 kDa
false
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : PANC-1, G-401, skeletal muscle.
The identity of the lower MW band at approximately 130 kDa (in lane 4) is unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-KIF13B antibody [EPR29559-519] (<a href='/products/primary-antibodies/kif13b-antibody-epr29559-519-ab327425'>ab327425</a>) at 1/1000 dilution
Lane 1:
NCI-H929 (human Bone B lymphocyte) whole cell lysate at 60 µg
Lane 2:
PANC-1 (human pancreatic epithelioid carcinoma epithelial cell) whole cell lysate at 60 µg
Lane 3:
G-401 (human rhabdoid tumor kidney epithelial cell) whole cell lysate at 60 µg
Lane 4:
Mouse liver tissue lysate at 60 µg
Lane 5:
Mouse skeletal muscle tissue lysate at 60 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 260 kDa,124 kDa
false
Exposure time: 158s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Performed under reducing conditions.
In Western blot, ab324875 was shown to bind specifically to Tet2 . Target of interest was observed at 260 kDa in wild-type HAP1 cell lysates (lane 1) with no signal observed at this size in Tet2 knockout cell line (lane 2).
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
The bands beneath the target band (260 kDa) are likely to be degraded target fragments.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-Tet2 antibody [EPR29630-29] (<a href='/products/primary-antibodies/tet2-antibody-epr29630-29-ab324875'>ab324875</a>) at 1/1000 dilution
Lane 1:
Wild-type HAP1 (human chronic myelogenous leukemia near-haploid cell) whole cell lysate at 20 µg
Lane 2:
Tet2 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 260 kDa,124 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-KIF13B antibody [EPR29559-519] (<a href='/products/primary-antibodies/kif13b-antibody-epr29559-519-ab327425'>ab327425</a>) at 1/1000 dilution
Lane 1:
A-204 (human muscle rhabdomyosarcoma cell) transfected with scrambled siRNA control whole cell lysate at 80 µg
Lane 2:
A-204 transfected with siRNA specifically targeting KIF13B whole cell lysate at 80 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Observed band size: 260 kDa,124 kDa
false
Exposure time: 6s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This blot was developed using a high-sensitivity ECL substrate, allowing for the detection of proteins in the mid-femtogram range.
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
The bands beneath the target band (260 kDa) are likely to be degraded target fragments.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-Tet2 antibody [EPR29630-29] (<a href='/products/primary-antibodies/tet2-antibody-epr29630-29-ab324875'>ab324875</a>) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) transfected with scrambled siRNA control whole cell lysate at 10 µg
Lane 2:
293T transfected with siRNA specifically targeting Tet2 whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 260 kDa,124 kDa
true
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Low expression : heart (PMID : 23591958).
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
Samples should not be boiled, as boiling may cause protein aggregation.
All lanes:
Western blot - Anti-CerS2 antibody [EPR28098-1] (<a href='/products/primary-antibodies/cers2-antibody-epr28098-1-ab315452'>ab315452</a>) at 1/1000 dilution
Lane 1:
HepG2 (human hepatocellar carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Mouse brain tissue lysate at 20 µg
Lane 3:
Mouse heart tissue lysate at 20 µg
Lane 4:
Rat brain tissue lysate at 20 µg
Lane 5:
Rat heart tissue lysate at 20 µg
Lane 6:
Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 40 kDa,124 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This blot was developed using a high-sensitivity ECL substrate, allowing for the detection of proteins in the mid-femtogram range.
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
In Western blot, Anti-Vinculin antibody [EPR8185] ab129002 staining at 1/10000 dilution.
All lanes:
Western blot - Anti-KDM6B / JMJD3 antibody [EPR28325-184] (<a href='/products/primary-antibodies/kdm6b-jmjd3-antibody-epr28325-184-ab324740'>ab324740</a>) at 1/1000 dilution
Lane 1:
K-562 (human chronic myelogenous leukemia lymphoblast) transfected with scrambled siRNA control whole cell fresh lysate at 20 µg
Lane 2:
K-562 transfected with siRNA specifically targeting KDM6B whole cell fresh lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 200 kDa,124 kDa
true
Exposure time: 92s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The identity of the bands lower than 180 kDa are unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-Werner's syndrome helicase WRN antibody [EPR29645-145] (<a href='/products/primary-antibodies/werners-syndrome-helicase-wrn-antibody-epr29645-145-ab327707'>ab327707</a>) at 1/1000 dilution
All lanes:
Human testis tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 200 kDa,124 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, ab327426 was shown to bind specifically to CCNE1. Target of interest was observed at 35-50 kD in wild-type HCT116 cell lysates (lanes 1-2) with no signal observed at this size in the CCNE1 knockout cell line (lanes 3-4) (lanes 3-4, knockout cell line ab286494).
The identity of the higher MW band at approximately 150 kDa is unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-Cyclin E1(Phospho T77) antibody [EPR28889-10] (<a href='/products/primary-antibodies/cyclin-e1phospho-t77-antibody-epr28889-10-ab327426'>ab327426</a>) at 1/1000 dilution
Lane 1:
Untreated HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate (untreated membrane) at 50 µg
Lane 2:
HCT 116 treated with 2.5mM Thymidine for 16h whole cell lysate (untreated membrane) at 50 µg
Lane 3:
CCNE1 knockout HCT116 whole cell lysate (untreated membrane) at 50 µg
Lane 4:
CCNE1 knockout HCT116 treated with 2.5mM Thymidine for 16h) whole cell lysate (untreated membrane) at 50 µg
Lane 5:
Untreated HCT 116 whole cell lysate (alkaline phosphatase treated membrane) at 50 µg
Lane 6:
HCT 116 treated with 2.5mM Thymidine for 16h whole cell lysate (alkaline phosphatase treated membrane) at 50 µg
Lane 7:
CCNE1 knockout HCT116 whole cell lysate (alkaline phosphatase treated membrane) at 50 µg
Lane 8:
CCNE1 knockout HCT116 treated with 2.5mM Thymidine for 16h whole cell lysate (alkaline phosphatase treated membrane) at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 35-50 kDa,124 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Performed under reducing conditions.
In Western blot, ab327421 was shown to bind specifically to Talin 1. Target of interest was observed at 269, 250, 240 kDa in wild-type PC-3 cell lysates (lane 1) with no signal observed at this size in TLN1 knockout cell line (lane 2) (lane 2, knockout cell line ab290495).
Low expression : TT.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-Talin 1 antibody [EPR29641-30] (<a href='/products/primary-antibodies/talin-1-antibody-epr29641-30-ab327421'>ab327421</a>) at 1/1000 dilution
Lane 1:
Wild-type PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Western blot - Human TLN1 knockout PC-3 cell line (<a href='/products/cell-lines/human-tln1-knockout-pc-3-cell-line-ab290495'>ab290495</a>) at 20 µg
Lane 3:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 4:
bEnd.3 (mouse brain endothelial cell) whole cell lysate at 20 µg
Lane 5:
SK-OV-3 (human ovarian cancer epithelial cell) whole cell lysate at 20 µg
Lane 6:
LN-229 (human brain glioblastoma epithelial cell) whole cell lysate at 20 µg
Lane 7:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 8:
TT (human thyroid carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 269 kDa,250 kDa,240 kDa,124 kDa
false
Exposure time: 70s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
To minimize protein degradation, the fresh lysates were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
The identity of the lower MW bands are likely to be degradation fragments.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-ASXL2 antibody [EPR27482-289] (<a href='/products/primary-antibodies/asxl2-antibody-epr27482-289-ab327007'>ab327007</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 3:
THP-1 (human monocytic leukemia monocyte) whole cell lysate at 20 µg
Lane 4:
Jurkat (human T cell leukemia T lymphocyte from peripheral blood) whole cell lysate at 20 µg
Lane 5:
RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 210 kDa,124 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
To minimize protein degradation, the fresh lysates were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
The identity of the lower MW bands are likely to be degradation fragments.
Lanes 3-4 of this blot was developed using a high-sensitivity ECL substrate, allowing for the detection of proteins in the mid-femtogram range.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-ASXL2 antibody [EPR27482-289] (<a href='/products/primary-antibodies/asxl2-antibody-epr27482-289-ab327007'>ab327007</a>) at 1/1000 dilution
Lane 1:
3T3-L1 (mouse embryonic fibroblast) transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 2:
3T3-L1 transfected with siRNA specifically targeting ASXL2 whole cell lysate at 20 µg
Lane 3:
U-2 OS (human bone osteosarcoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 4:
U-2 OS transfected with siRNA specifically targeting ASXL2 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 210 kDa,124 kDa
true
Exposure time: 180s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : spleen, kidney, cerebellum.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 36054350).
Samples are non-boiled as boiling may cause protein aggregation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
Exposure time : Lanes 1-4 : 59 seconds, lanes 5-7 : 180 seconds
All lanes:
Western blot - Anti-Muscarinic Acetylcholine Receptor 1/CHRM1 antibody [EPR26494-240] (<a href='/products/primary-antibodies/muscarinic-acetylcholine-receptor-1-chrm1-antibody-epr26494-240-ab325432'>ab325432</a>) at 1/1000 dilution
Lane 1:
Mouse cerebral cortex tissue lysate at 50 µg
Lane 2:
Mouse kidney tissue lysate at 50 µg
Lane 3:
Mouse spleen tissue lysate at 50 µg
Lane 4:
Mouse cerebellum tissue lysate at 50 µg
Lane 5:
Human cerebral cortex tissue lysate at 50 µg
Lane 6:
Human spleen tissue lysate at 50 µg
Lane 7:
Human cerebellum tissue lysate at 50 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 75 kDa,124 kDa
false
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-UBP43/USP18 antibody [EPR26174-540] (<a href='/products/primary-antibodies/ubp43-usp18-antibody-epr26174-540-ab325178'>ab325178</a>) at 1/1000 dilution
All lanes:
Human tonsil tissue lysate at 50 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 35 kDa,37 kDa,124 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression of NLRC5 is upregulated in response to IFN gamma treatment (PMID : 36103539; PMID : 20610642; PMID : 20061403).
This antibody can recognize the different isoforms of NLRC5.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-NLRC5 antibody [EPR29722-55] (<a href='/products/primary-antibodies/nlrc5-antibody-epr29722-55-ab325273'>ab325273</a>) at 1/1000 dilution
Lane 1:
Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa treated with 1000U/ml IFN gamma for 6 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 205 kDa,170 kDa,124 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : human liver, human spleen.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
Exposure time :
Lanes 1-3 : 10 seconds;
Lane 4 : 48 seconds.
All lanes:
Western blot - Anti-EMP2 antibody [EPR30305-511] (<a href='/products/primary-antibodies/emp2-antibody-epr30305-511-ab326423'>ab326423</a>) at 1/1000 dilution
Lane 1:
Human lung tissue lysate at 20 µg
Lane 2:
Human liver tissue lysate at 20 µg
Lane 3:
Human spleen tissue lysate at 20 µg
Lane 4:
A431 (human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 20-50 kDa,124 kDa
false
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : 293T(PMID : 10934049)
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) 1 : 10000 (124Kda).
All lanes:
Western blot - Anti-PTPN14 antibody [EPR30487-534] (<a href='/products/primary-antibodies/ptpn14-antibody-epr30487-534-ab326098'>ab326098</a>) at 1/1000 dilution
Lane 1:
DU 145 (human prostate carcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 80 µg
Lane 2:
DU 145 transfected with siRNA specifically targeting PTPN14 whole cell lysate at 80 µg
Lane 3:
293T (human embryonic kidney epithelial cell) whole cell lysate at 80 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 135 kDa,124 kDa
false
Exposure time: 135s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : lung.
The molecular weight observed is consistent with what has been described in the literature (PMID : 18940796).
The identity of the higher MW band at approximately 250 kDa (in lane 1) is unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-ITGA7 antibody [EPR28509-556] (<a href='/products/primary-antibodies/itga7-antibody-epr28509-556-ab325935'>ab325935</a>) at 1/1000 dilution
Lane 1:
Human skeletal muscle tissue lysate at 40 µg
Lane 2:
Human bladder tissue lysate at 40 µg
Lane 3:
Human lung tissue lysate at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 70 kDa,100 kDa,128 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-UBP43/USP18 antibody [EPR26174-540] (<a href='/products/primary-antibodies/ubp43-usp18-antibody-epr26174-540-ab325178'>ab325178</a>) at 1/1000 dilution
Lane 1:
Untreated THP-1 (human monocytic leukemia monocyte) whole cell lysate at 50 µg
Lane 2:
THP-1 treated with 1 ug/ml LPS for 8 hours whole cell lysate at 50 µg
Lane 3:
Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 50 µg
Lane 4:
HeLa treated with 10ng/ml IFN alpha (human) for 16 hours whole cell lysate at 50 µg
Lane 5:
Untreated MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate at 50 µg
Lane 6:
MCF7 treated with 100U/ml IFN alpha (human) for 24 hours whole cell lysate at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 35 kDa,37 kDa,124 kDa
false
Exposure time: 6s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : spleen.
250 kDa full length band and 120-130 kDa cleavage fragment band were ovserved (PMID : 20471383).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-Robo1 antibody [EPR29534-534] (<a href='/products/primary-antibodies/robo1-antibody-epr29534-534-ab326048'>ab326048</a>) at 1/1000 dilution
Lane 1:
Human breast cancer tissue lysate at 20 µg
Lane 2:
Human liver cancer tissue lysate at 20 µg
Lane 3:
Human colon cancer tissue lysate at 20 µg
Lane 4:
Human spleen tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 120-130 kDa,124 kDa
false
Exposure time: 37s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : MCF7, LoVo.
250 kDa full length band and 120-130 kDa cleavage fragment band were ovserved (PMID : 20471383).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-Robo1 antibody [EPR29534-534] (<a href='/products/primary-antibodies/robo1-antibody-epr29534-534-ab326048'>ab326048</a>) at 1/1000 dilution
Lane 1:
HAP1 (human chronic myelogenous leukemia near-haploid cell) whole cell lysate at 20 µg
Lane 2:
U-87 MG (human glioblastoma-astrocytoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
LoVo (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 6:
SW480 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 120-130 kDa,250 kDa,124 kDa
false
Exposure time: 37s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
Exposure time : Lanes 1-3 : 10 seconds, lanes 4-5 : 180 seconds
All lanes:
Western blot - Anti-INO80 antibody [EPR30384-761] (<a href='/products/primary-antibodies/ino80-antibody-epr30384-761-ab325542'>ab325542</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 50 µg
Lane 2:
LoVo (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 50 µg
Lane 3:
SW480 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 50 µg
Lane 4:
CT26.WT (mouse colon fibroblast) whole cell lysate at 50 µg
Lane 5:
B16-F10 (mouse skin melanoma cell) whole cell lysate at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 200 kDa,124 kDa
false
不同偶联物与剂型 (5)
-
Anti-Vinculin antibody [EPR8185] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Vinculin antibody [EPR8185]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Vinculin antibody [EPR8185]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Vinculin antibody [EPR8185]
-
HRP Anti-Vinculin antibody [EPR8185] - Loading Control
反应性数据
产品详情
Anti-Vinculin antibody [EPR8185] (ab129002) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IP and WB.
Anti-Vinculin antibody [EPR8185] (ab129002) was first used in a scientific publication in 2013 and has been cited over 356 times in peer reviewed journals. It's performance in Western Blot in mouse and human samples is trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-Vinculin antibody [EPR8185] (ab129002) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-Vinculin antibody [EPR8185] (ab129002) has been confirmed by Western Blot testing in Vinculin knockout A431 cells.
Anti-Vinculin antibody [EPR8185] (ab129002) has 21 independent reviews from customers.
Vinculin antibodies are often used as loading controls in Western Blot. Anti-Vinculin antibody [EPR8185] has been verified in Western Blot samples and detects a band at 124kDa Molecular weight.
Anti-Vinculin antibody [EPR8185] (ab129002) specifically detects Vinculin (UniProt ID: P18206; Molecular weight: 124kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL, 250 µL and 1 mL).
Conjugation-ready, carrier free format available for antibody clone EPR8185 - ab217171.
Antibody clone EPR8185 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, Alexa Fluor® 555 (ab196454, ab196579, ab206908).
Vinculin is a focal adhesion protein that plays a critical role in cell adhesion, migration and mechanotransduction. In oncology, it influences tumor progression and metastasis by modulating the interactions between cancer cells and the extracellular matrix.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (524)
Recent publications for all applications. Explore the full list and refine your search
Cell reports. Medicine :102924 PubMed42468534
2026
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:675 PubMed41053099
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:113449 PubMed41050429
2025
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 10: PubMed40996961
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 21:5586-5608 PubMed40959291
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica et biophysica Sinica : PubMed40931756
2025
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 86:103839 PubMed40876441
2025
Applications
Unspecified application
Species
Unspecified reactive species
Extracellular vesicle 5: PubMed40642206
2025
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 44:4525-4551 PubMed40624280
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:5980 PubMed40593658
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com